New Results
Development of photoactivatable drugs enables nicotinic optopharmacology
Sambashiva Banala, Matthew C. Arvin, Nicolas M. Bannon, Xiao-Tao Jin, Yong Wang, Guiqing Zhao, John J. Marshall, Kyle R. Gee, David L. Wokosin, Anis Contractor, Henry A. Lester, View ORCID ProfileYevgenia Kozorovitskiy, View ORCID ProfileRyan M. Drenan, View ORCID ProfileLuke D. Lavis
doi: https://doi.org/10.1101/260232
Sambashiva Banala
1Janelia Research Campus, Howard Hughes Medical Institute, Ashburn, VA, USA
Matthew C. Arvin
2Departments of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
Nicolas M. Bannon
4Department of Neurobiology, Weinberg School of Arts and Sciences, Northwestern University, Evanston, IL, USA
Xiao-Tao Jin
2Departments of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
Yong Wang
2Departments of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
Guiqing Zhao
2Departments of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
John J. Marshall
3Departments of Physiology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
Kyle R. Gee
5Molecular Probes, ThermoFisher, Eugene, OR, USA
David L. Wokosin
3Departments of Physiology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
Anis Contractor
3Departments of Physiology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
4Department of Neurobiology, Weinberg School of Arts and Sciences, Northwestern University, Evanston, IL, USA
Henry A. Lester
1Janelia Research Campus, Howard Hughes Medical Institute, Ashburn, VA, USA
6Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA
Yevgenia Kozorovitskiy
4Department of Neurobiology, Weinberg School of Arts and Sciences, Northwestern University, Evanston, IL, USA
Ryan M. Drenan
2Departments of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
Luke D. Lavis
1Janelia Research Campus, Howard Hughes Medical Institute, Ashburn, VA, USA
Posted February 05, 2018.
Development of photoactivatable drugs enables nicotinic optopharmacology
Sambashiva Banala, Matthew C. Arvin, Nicolas M. Bannon, Xiao-Tao Jin, Yong Wang, Guiqing Zhao, John J. Marshall, Kyle R. Gee, David L. Wokosin, Anis Contractor, Henry A. Lester, Yevgenia Kozorovitskiy, Ryan M. Drenan, Luke D. Lavis
bioRxiv 260232; doi: https://doi.org/10.1101/260232
Development of photoactivatable drugs enables nicotinic optopharmacology
Sambashiva Banala, Matthew C. Arvin, Nicolas M. Bannon, Xiao-Tao Jin, Yong Wang, Guiqing Zhao, John J. Marshall, Kyle R. Gee, David L. Wokosin, Anis Contractor, Henry A. Lester, Yevgenia Kozorovitskiy, Ryan M. Drenan, Luke D. Lavis
bioRxiv 260232; doi: https://doi.org/10.1101/260232
Subject Area
Subject Areas
- Biochemistry (11699)
- Bioengineering (8715)
- Bioinformatics (29119)
- Biophysics (14927)
- Cancer Biology (12047)
- Cell Biology (17347)
- Clinical Trials (138)
- Developmental Biology (9405)
- Ecology (14138)
- Epidemiology (2067)
- Evolutionary Biology (18261)
- Genetics (12216)
- Genomics (16760)
- Immunology (11839)
- Microbiology (27996)
- Molecular Biology (11549)
- Neuroscience (60781)
- Paleontology (450)
- Pathology (1864)
- Pharmacology and Toxicology (3228)
- Physiology (4937)
- Plant Biology (10382)
- Synthetic Biology (2876)
- Systems Biology (7332)
- Zoology (1642)